Jeff Yass’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Jeff Yass’s Portfolio BTTX Stock Details BTTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-38,057	Closed	-$7.42K	–	13740
2023 Q4	$7.42K	Buy	+38,057	New	+$8.27K	﹤0.01%	12097
2023 Q2	–	Sell	-47,516	Closed	-$34.6K	–	13484
2023 Q1	$34.6K	Sell	47,516 -6,473	-12%	-$7.6K	﹤0.01%	11856
2022 Q4	$60.5K	Sell	53,989 -17,477	-24%	-$25.8K	﹤0.01%	11286
2022 Q3	$126K	Buy	71,466 +3,084	+5%	+$5.63K	﹤0.01%	11468
2022 Q2	$107K	Buy	+68,382	New	+$114K	﹤0.01%	11421
2021 Q4	–	Sell	-14,067	Closed	-$115K	–	14133
2021 Q3	$140K	Buy	+14,067	New	+$140K	﹤0.01%	11844

Other funds holding BTTX

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

APC

Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Jeff Yass's BTTX Position: Q1 2024 in Review

Jeff Yass sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q1 2024, closing a stake of 38,057 shares — an estimated $7.42K sold.

Jeff Yass first reported a position in BTTX in Q3 2021 and held it in 6 quarters. The position peaked at $140K in Q3 2021. 3 funds tracked by Wall St. Rank hold BTTX as of Q1 2024.

Jeff Yass reported no remaining Better Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Jeff Yass sold 38,057 Better Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $7.42K.
Jeff Yass first reported a position in Better Therapeutics, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
Jeff Yass's Better Therapeutics, Inc. Common Stock position peaked at $140K in Q3 2021.
3 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.